In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness FDA and FTC Issue 13 Warning Letters to E liquid Companies for Misleadingly Marketing to Youth; FDA Investigates Underage Use of JUUL Devices The Continuum of Risk FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP 1 products. This marks the second round of enforcement action since the agency's September crackdown on misleading New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,